Saturday, October 19, 2019
| 8:00 AM | 8:10 AM | Opening remarks, welcome, and a description of the program |
| 8:10 AM | 8:30 AM | Primer on Cancer Immunology and Immuno-Oncology (Innate vs Adaptive T Cell Immunity and Biomarkers) |
| 8:30 AM | 8:50 AM | Tumor Microenvironment and Immuno-Oncology |
| 8:50 AM | 9:10 AM | Immunotherapy in GI Cancer |
| 9:10 AM | 9:30 AM | Immunotherapy in Hepatocellular Carcinoma |
| 9:30 AM | 9:50 AM | Immunotherapy in Cholangiocarcinoma |
| 10:10 AM | 10:30 AM | Immunotherapy in Colorectal Cancer and future direction |
| 11:20 AM | 11:40 AM | Immuno-Radiation |
| 11:40 AM | 12:00 PM | Immuno-Ablation |
| 1:00 PM | 1:20 PM | Abscopal Effects: Myth? or Facts? |
| 1:20 PM | 1:40 PM | Microbiome and Immune therapy |
| 1:40 PM | 2:00 PM | Oligometastatic / Oligoprogression Disease and New Treatment Paradigm |
| 2:00 PM | 2:20 PM | Pseudo-progression/Hyper-progression and immuno-oncology |
| 2:20 PM | 2:40 PM | Functional imaging for immuno-oncology |
| 2:40 PM | 3:00 PM | Radiomics and Immuno Oncology |
| 3:30 PM | 3:45 PM | Immune-Embolization |
| 3:45 PM | 4:00 PM | Intratumoral and Oncoviral Immunotherapy |
| 4:00 PM | 4:15 PM | TILs therapy and Interventional Oncology |
| 4:15 PM | 4:30 PM | CAR T Cells and Interventional Oncology |
| 4:30 PM | 5:00 PM | Q&A and Concluding remarks |
